Abstract Coronavirus disease 2019 (COVID-19) associated coagulopathy is multifactorial
and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet …

As COVID-19 evolves from a pandemic to an endemic disease, the already staggering
number of people that have been or will be infected with SARS-CoV-2 is only destined to …

The global scope and scale of the SARS-CoV-2 pandemic led to huge amounts of important
data from clinical observations and experimental analyses being collected, in particular …

Background and Objectives: Increasing attention is being paid to the coagulation disorders
associated with SARS-CoV-2 infection. Bleeding accounts for 3–6% of COVID-19 patient …

Importance The COVID-19 pandemic led to the use of lung transplant as a lifesaving therapy
for patients with irreversible lung injury. Limited information is currently available regarding …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused
coronavirus diseases (COVID-19) in late 2019 in China created a devastating economical …

The ongoing pandemic of the coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 still has limited treatment options. Our …

Pulmonary embolism (PE) is a serious medical condition that can occur as a result of venous
thromboembolism (VTE). COVID-19, also known as Post-Acute Sequelae of SARS-CoV-2 …

BACKGROUND: The predictive value of coagulation markers for venous thromboembolism
(VTE) in COVID-19 patients has been investigated with conflicting results. OBJECTIVE: Our …

Blood coagulation is a complicated dynamic process that maintains the blood's fluid state
and prevents uncontrollable bleeding. The real-time monitoring of coagulation dynamics is …